EP1138679A1 - HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF - Google Patents
HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF Download PDFInfo
- Publication number
- EP1138679A1 EP1138679A1 EP99959746A EP99959746A EP1138679A1 EP 1138679 A1 EP1138679 A1 EP 1138679A1 EP 99959746 A EP99959746 A EP 99959746A EP 99959746 A EP99959746 A EP 99959746A EP 1138679 A1 EP1138679 A1 EP 1138679A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- group
- denotes
- substituted
- lower alkyl
- hydrogen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CO[C@]([C@@]1C[C@@]2[C@@]3CCCC2)O[C@@](*)C1C3=C Chemical compound CO[C@]([C@@]1C[C@@]2[C@@]3CCCC2)O[C@@](*)C1C3=C 0.000 description 5
- RNYZJZKPGHQTJR-UHFFFAOYSA-N C=C(C=C1)OC1=O Chemical compound C=C(C=C1)OC1=O RNYZJZKPGHQTJR-UHFFFAOYSA-N 0.000 description 1
- QEDQAGYIFVOLSE-HEIVXVCXSA-N C[C@@H]([C@@H]([C@@H]1C[C@@H]2[C@H]3CCCCCC2)C3=O)O[C@@H]1OC Chemical compound C[C@@H]([C@@H]([C@@H]1C[C@@H]2[C@H]3CCCCCC2)C3=O)O[C@@H]1OC QEDQAGYIFVOLSE-HEIVXVCXSA-N 0.000 description 1
- DXZWCQVDTFHTHR-GTCGHBQESA-N C[C@@H]([C@@H]1C[C@H]2C3CCCC2)O[C@H](C)[C@H]1[C@H]3O Chemical compound C[C@@H]([C@@H]1C[C@H]2C3CCCC2)O[C@H](C)[C@H]1[C@H]3O DXZWCQVDTFHTHR-GTCGHBQESA-N 0.000 description 1
- PHOHZPXRQXYAEE-WWBIDZNWSA-N C[C@@H]([C@@H]1C[C@H]2[C@H]3CCCC2)O[C@H](C)[C@H]1C3=O Chemical compound C[C@@H]([C@@H]1C[C@H]2[C@H]3CCCC2)O[C@H](C)[C@H]1C3=O PHOHZPXRQXYAEE-WWBIDZNWSA-N 0.000 description 1
- AUDIISGPMIIBOJ-NSZSAUCHSA-N C[C@@H]1O[C@H](C)[C@H]2[C@@H](CO)C(CCCC3)[C@@H]3C[C@@H]12 Chemical compound C[C@@H]1O[C@H](C)[C@H]2[C@@H](CO)C(CCCC3)[C@@H]3C[C@@H]12 AUDIISGPMIIBOJ-NSZSAUCHSA-N 0.000 description 1
- SPXIGEQLEYOESE-TURHLZRKSA-N C[C@H]([C@H]([C@H]1CC2C3CCCC2)[C@H]3O)OC1=O Chemical compound C[C@H]([C@H]([C@H]1CC2C3CCCC2)[C@H]3O)OC1=O SPXIGEQLEYOESE-TURHLZRKSA-N 0.000 description 1
- TYRPWLLFRPBGJS-ABEFPOLGSA-N C[C@H]([C@H]12)OC3OC3C1[C@@H]1O[C@H]2C2=C1CCCC2 Chemical compound C[C@H]([C@H]12)OC3OC3C1[C@@H]1O[C@H]2C2=C1CCCC2 TYRPWLLFRPBGJS-ABEFPOLGSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Definitions
- the present invention relates to novel hydronaphtho [2,3-c] -furan derivatives being preparative intermediates of himbacine, which exhibits potent and selective antagonism against muscarine M 2 receptor and is expected for the use as a therapeutic drug of Arzheimer's disease, and process for preparing the same.
- Himbacine is a piperidine alkaloid, which was isolated from Galbulimima baccata being one species of pinaceous plant and the structure of which was determined in 1956, and, as the structural characteristics thereof, three points of condensation of 5-membered lactone ring to thermodynamically stable transdecalin ring in cis configuration, eight asymmetric centers including four internuclear hydrogens, and further binding of 3-cyclic portion with piperidine ring via trans double bond can be mentioned.
- inventive compounds are useful as the intermediates in the preparation of himbacine using the intermolecular Diels-Alder reaction as a key reaction, leading to the completion of the invention.
- the invention provides hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1) (wherein R 1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R 2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R 3 and R 4 unitedly denote an oxygen atom or methylene group, or R 3 denotes a hydrogen atom and R 4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, R 5 and R 6 unitedly denote an oxygen atom, or R 5 denotes a hydrogen atom and R 6 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and, in the case of broken lines accompanied, one denotes single bond and
- lower alkyls straight chain or branched ones with carbon atoms of 1 to 6 such as methyl, ethyl, 1-methylethyl, 1,1-dimethylethyl, propyl and 2-methylpropyl are mentioned and it doesn't matter whether saturated or unsaturated.
- aralkyl groups benzyl group, 1-phenylethyl group, etc. are mentioned and, as substituents, lower alkyl group, lower alkoxy group, halogen atom, cyano group, nitro group, etc. are mentioned.
- lower alkoxy group straight chain or branched ones with carbon atoms of 1 to 6 such as methoxy, ethoxy, 1-methylethoxy, 1,1-dimethylethoxy, propoxy and 2-methylpropoxy are mentioned and it doesn't matter whether saturated or unsaturated.
- aralkyloxy groups benzyloxy group, 1-phenylethoxy group, etc. are mentioned and, as substituents, lower alkyl group, lower alkoxy group, halogen atom, cyano group, nitro group, etc. are mentioned.
- lower acyl groups ones with carbon atoms of 1 to 6 such as formyl group, acetyl group, propionyl group and 2,2-dimethylpropionyl group are mentioned
- lower acyloxy groups ones with carbon atoms of 1 to 6 such as formyloxy group, acetoxy group, propionyloxy group and 2,2-dimethylpropionyl group are mentioned.
- trialkylsilyl groups such as trimethylsilyl group and t-butyldimethylsilyl group
- arylmethyl groups such as benzyl group and diphenylmethyl group
- acyl groups such as acetyl group and propionyl group
- lower alkoxymethyl groups such as methoxymethyl group and ethoxymethyl group'
- aralkyloxymethyl groups such as benzyloxymethyl group, tetrahydropyranyl group, and the like
- the compounds of said general formula (4) can be prepared by publicly known processes (Beckmann, M. et al, Tetrahedron: Asymmetry, 1990, 1, 335 etc.).
- the compounds of general formula (5) can be prepared by publicly known processes (Spencer, T.A. et al, J. Am. Chem. Soc., 1973, 95, 250 etc.).
- inventive compounds have a plurality of asymmetric carbon atoms and corresponding optical isomers can exist, but these optical isomers and their mixtures are to be included in the invention.
- the compounds represented by general formula (1) and (2) in the invention can be prepared according to following preparative processes, making the compounds represented by said general formula (3a) synthesizable from the compounds represented by said general formula (4) and (5) as key intermediates.
- This process is for preparing 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3a) by adding 4,5,6,7-tetrahydroisobenzofuran represented by said general formula (5) to (S)-5-lower alkyl-2(5H)-furanone represented by said general formula (4).
- This reaction can be conducted in the presence or absence of Lewis acid such as zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex or lithium perchlorate, rhodium complex such as Wilkinson's complex, sodium dodecylsulfate or cetyltrimethyl ammonium bromide.
- Lewis acid such as zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex or lithium perchlorate, rhodium complex such as Wilkinson's complex, sodium dodecylsulfate or cetyltrimethyl ammonium bromide.
- the reaction is conducted in the presence or absence of, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, aprotic polar solvent such as acetonitrile, propionitrile, nitromethane, nitroethane, N,N-dimethylformamide or dimethyl sulfoxide, or mixed solvent of one of these with water, and usually proceeds smoothly at -20°C to 200°C. Also, as the case may be, stabilizers like radical eliminator such as 2,6-di-t-butyl-4-methylphenol (BHT), etc. may be added.
- hydrocarbonic solvent such as pent
- This process is for catalytically reducing the double bond in 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3a), obtainable in the first process aforementioned, to prepare 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3b).
- This reaction is conducted usually in solvent, using catalyst such as palladium-carbon, Raney nickel, palladium hydroxide, rhodium-alumina or platinum oxide.
- a solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene, or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,3-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of one of these with water is used preferably.
- the reaction
- This process is for cutting the ether bond of 4,9-epoxydecahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3b), obtainable in the second process aforementioned, to prepare octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1a).
- alkali metal alkoxide such as sodium methoxide or sodium ethoxide
- alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide
- tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methylmorpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo[4.3.0]nona-5-ene or 1,8-diazabicyclo[5.4.0]ude-7-cene
- Lewis acid such as zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex or lithium perchlorate.
- any solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, or ethereal solvent such as diethyl ether, tetrahydofuran or 1,4-dioxane is used preferably.
- hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene
- halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride
- ethereal solvent such as diethyl ether, tetrahydofuran or 1,
- This process is for isomerizing the double bond of octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1a), obtainable in the third process aforementioned, using a suitable base, to prepare octahydronaphtho-[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1b).
- This reaction can be conducted in the presence of, for example, alkali metal alkoxide such as sodium methoxide or sodium ethoxide, alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide, or tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methyl-morpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo-[4.3.0]nona-5-ene or 1,8-diazabicyclo[5.4.0]unde-7-cene.
- alkali metal alkoxide such as sodium methoxide or sodium ethoxide
- alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl
- any solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably.
- the reaction proceeds smoothly at -110°C to 100°C .
- This process is for catalytically reducing the double bond in octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1b), obtainable in the fourth process aforementioned, to prepare decahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1c).
- This reaction is conducted usually in solvent, using catalyst such as palladium-carbon, Raney nickel, palladium hydroxide, rhodium-alumina or platinum oxide.
- a solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of one of these with water is used preferably.
- the reaction proceeds
- This process is for reducing the lactonecarbonyl bond in decahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1c), obtainable in the fifth process aforementioned, and further for protecting 1-hydroxyl group of 1,4-dihydroxy-dodecahydronaphtho[2,3-c]furan derivatives produced by selective alkylation, to prepare 1-alkoxy-4-hydroxy-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2a).
- dialkylaluminum hydride such as diisobutylaluminum hydride.
- a solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, or ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane is used.
- hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene
- halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride
- the etherification of 1-position hydroxyl group to be conducted successively is performed in alcohol solvent in the presence of a suitable Lewis acid.
- a suitable Lewis acid for example, zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex, lithium perchlorate or the like is mentioned, and, as the alcohol solvent, for example, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably.
- the reaction usually proceeds smoothly at -100°C to 100°C.
- aralkyl group or acyl group to 1-position hydroxyl group to be conducted successively is performed according to publicly known methods (Green, T.W.; Wuts, P.G.M. "Protective Groups in Organic Synthesis", 2 nd Ed., Wiley Interscience Publication, John-Weiley & Sons, New York, 1991, pp 46-66 and pp 87-118).
- This process is for oxidizing the 4-position hydroxyl group in 4-hydroxydodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2a), obtainable in the sixth process aforementioned, to prepare 4-oxododecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2b).
- chromic acid chromic trioxide-pyridine mixed system, dimethyl sulfoxide-oxalyl chloride-triethylamine mixed system, ruthenium complex, Dess-Martin reagent or the like can be used.
- the oxidation is usually preferable to be conducted in solvent and, for example, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride is used.
- halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride is used.
- the reaction proceeds smoothly at -100°C to 100°C.
- This reaction is for conducing Wittig reaction by reacting ylide prepared from methyltriphenylphosphonium salt and base, with 4-position carbonyl group in 4-oxododecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2b), obtainable in the seventh process aforementioned, to prepare 4-methylenedodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2c).
- methyltriphenylphosphonium chloride methyltriphenylphosphonium bromide or methyltriphenylphosphonium iodide
- the reaction can be conducted in the presence of, for example, alkali metal alkoxide such as sodium methoxide or sodium ethoxide, alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide, or tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methylmorpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo[4.3.0]non-5-ene or 1,8-diazabicyclo[5.4.0]undec-7-ene as a base to be used.
- alkali metal alkoxide such as sodium methoxide or sodium ethoxide
- any solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably.
- hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene
- halogenated hydrocarbonic solvent such as dichloromethan
- This reaction is for conducting hydroboraton and oxidation reaction to 4-position methylene group in 4-methylene-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2c), obtainable in the eighth process aforementioned, to prepare 4-hydroxymethyl-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (2a).
- hydroborating agent to be used in this reaction for example, borane-tetrahydrofuran complex, borane-dimethyl sulfide complex, 9-borabicyclo[3,3,1]nonane or the like is mentioned and, as a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or mixed solvent thereof is used.
- hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene
- aqueous hydrogen peroxide, m-chloroperbenzoic acid, peracetic acid or the like is used.
- a solvent any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of
- the 4-hydroxy-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (2a), synthesized through the synthetic processes as described above are derived to 4-phenylsulfonylmethyl-decahydronaphtho[2,3-c]furan derivatives by sulfonation of 4-position hydroxymethyl group, substitution of 4-position sulfonyloxymethyl group with phenylthio group, and oxidation of 4-position phenylthiomethyl group to phenylsulfonylmethyl group, according to the synthetic method of Kozikowski et al (Kozikowski, A.P. et al, J. Am. Chem. Soc., 1995, 117, 9369) (see Referential example 1).
- Solvent was distilled off and 100ml of ethyl acetate were added to the residue, which was filtered through celite, and the residue was washed with ethyl acetate(50ml). Solvent was distilled off and 100ml of saturated brine were added, which was extracted with methylene chloride(30mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off to obtain crude lactol form.
- Acetic acid was added to the reaction mixture to make neutral and, after stirring further for 1 hour, 20ml of cold dilute aqueous solution of sodium hydroxide were added to make alkaline and solvent was distilled off under reduced pressure. The residue was extracted with ether(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off.
- Example 2 0.22g(10% by weight) of 10% palladium-carbon were added to 2.20g(9.99mmol) of (3R,3aR,4R,9S,9aS)-4,9-epoxy-3-methyl-3a,4,5,6,7,8,9,9a-octahydronaphtho[2,3-c]furan-1(3H)-one in 5ml of ethanol solution and catalytic reduction was conducted at ambient temperature under 98.1Kpa to obtain 1.36g of (3R,3aR,4S,4aR,8aS,9R,9aS)-4,9-epoxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(yield 61%). [ ⁇ ] D 23 -50° (c 0.68, CHCl 3 ) mp.148-149°C (hexane-ethyl acetate) Colorless flaky crystals
Abstract
Description
- The present invention relates to novel hydronaphtho [2,3-c] -furan derivatives being preparative intermediates of himbacine, which exhibits potent and selective antagonism against muscarine M2 receptor and is expected for the use as a therapeutic drug of Arzheimer's disease, and process for preparing the same.
- Himbacine is a piperidine alkaloid, which was isolated from Galbulimima baccata being one species of pinaceous plant and the structure of which was determined in 1956, and, as the structural characteristics thereof, three points of condensation of 5-membered lactone ring to thermodynamically stable transdecalin ring in cis configuration, eight asymmetric centers including four internuclear hydrogens, and further binding of 3-cyclic portion with piperidine ring via trans double bond can be mentioned.
- In recent years, the senile dementia represented by Alzheimer type dementia has posed a significant problem socially and a substantial therapeutic drug therefore is desired earnestly. As one of approaches, from a phenomenon of decreased function of central cholinergic nerve in demential patients, development of therapeutic drugs based on so-called "choline hypothesis" is being advanced actively. Roughly classifying them, it is possible to divide into four below. Namely, they are (1) inhibitor of taking-in of choline, (2) inhibitor of acetylcholinesterase, (3) activator for synthesizing choline acetyltransferase and (4) compound acting on muscarine receptor (muscarine M1 against or M2 receptor antagonist). It has become clear recently that the himbacine exhibits potent and selective antagonistic action on M2 receptor that is considered to suppress the release of nerve terminal acetylcholine, hence the potential as an antidemential drug has been found.
- As described, the himbacine is a globally noteworthy compound from two points of potent activity and interesting chemical structure and, in recent years, its syntheses are reported by some groups. Thereamong, overall syntheses having intramolecular Diels-Alder reaction as a key reaction in all cases have been accomplished by groups of Kozikowski et al and Chackalamannil et al (Kozikowski, A.P. et al, J. Am. Chem. Soc., 1995, 117, 9369. Chackalamannil, S. et al, J. Am. Chem. Soc., 1996, 118, 9812). With these processes using intramolecular Diels-Alder reaction, however, there are problems of not only necessity for passing through troublesome processes in the synthesis of its skeleton, but also difficult synthesis of affinous compounds that become important for aiming at improved activity and decreased side effect. While, if using intermolecular Diels-Alder reaction, required constitutional units can be synthesized separately and each can be combined arbitrarily to react, thereby leading to easy synthesis of affinous compounds. However, it is the status quo that the synthesis of himbacine having such intermolecular Diels-Alder reaction as a key reaction has not yet been accomplished.
- As a result of diligent studies in view of the subjects aforementioned, the inventors have found that the following inventive compounds are useful as the intermediates in the preparation of himbacine using the intermolecular Diels-Alder reaction as a key reaction, leading to the completion of the invention.
- Namely, the invention provides hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, R5 and R6 unitedly denote an oxygen atom, or R5 denotes a hydrogen atom and R6 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and, in the case of broken lines accompanied, one denotes single bond and the other denotes double bond, or both denote single bonds), hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1-1) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and in the case of broken lines accompanied, one denotes single bond and the other denotes double bond, or both denote single bonds), hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1-2) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and R7 denotes a hydrogen atom, lower alkyl group, substituted or unsubstituted daralkyl group or lower acyl group), hydronaphtho[2,3-c]furan derivatives represented by a following general formula (2) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R7 denotes a hydrogen atom, lower alkyl group, substituted or unsubstituted aralkyl group or lower acyl group), and R8 denotes a hydrogen atom or protective group of hydroxyl group), and hydronaphtho[2,3-c]furan derivatives represented by a following general formula (3) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, and, in the case o'f broken line accompanied, it denotes single bond or double bond), and a process for preparing compounds represented by a following general formula (3a) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, and R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group), characterized by reacting compounds represented by a following general formula (4) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group), with compounds represented by a following general formula (5) (wherein R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group).
- In the invention, for "lower alkyls", straight chain or branched ones with carbon atoms of 1 to 6 such as methyl, ethyl, 1-methylethyl, 1,1-dimethylethyl, propyl and 2-methylpropyl are mentioned and it doesn't matter whether saturated or unsaturated. For "aralkyl groups", benzyl group, 1-phenylethyl group, etc. are mentioned and, as substituents, lower alkyl group, lower alkoxy group, halogen atom, cyano group, nitro group, etc. are mentioned. For "lower alkoxy group", straight chain or branched ones with carbon atoms of 1 to 6 such as methoxy, ethoxy, 1-methylethoxy, 1,1-dimethylethoxy, propoxy and 2-methylpropoxy are mentioned and it doesn't matter whether saturated or unsaturated. For "aralkyloxy groups", benzyloxy group, 1-phenylethoxy group, etc. are mentioned and, as substituents, lower alkyl group, lower alkoxy group, halogen atom, cyano group, nitro group, etc. are mentioned. For "lower acyl groups", ones with carbon atoms of 1 to 6 such as formyl group, acetyl group, propionyl group and 2,2-dimethylpropionyl group are mentioned, and, for "lower acyloxy groups", ones with carbon atoms of 1 to 6 such as formyloxy group, acetoxy group, propionyloxy group and 2,2-dimethylpropionyl group are mentioned. Moreover, for the protective groups of hydroxyl group, trialkylsilyl groups such as trimethylsilyl group and t-butyldimethylsilyl group, arylmethyl groups such as benzyl group and diphenylmethyl group, acyl groups such as acetyl group and propionyl group, lower alkoxymethyl groups such as methoxymethyl group and ethoxymethyl group', aralkyloxymethyl groups such as benzyloxymethyl group, tetrahydropyranyl group, and the like are mentioned, and the introduction and elimination thereof can be performed by appropriately adopting the methods described in the literature (Green, T.W.; Wuts, P.G.M. "Protective Groups in Organic Synthesis", 2nd Ed., Wiley Interscience Publication, John-Weiley & Sons, New York, 1991, pp 14-118).
- The compounds of said general formula (4) can be prepared by publicly known processes (Beckmann, M. et al, Tetrahedron: Asymmetry, 1990, 1, 335 etc.). Similarly, the compounds of general formula (5) can be prepared by publicly known processes (Spencer, T.A. et al, J. Am. Chem. Soc., 1973, 95, 250 etc.). Besides the inventive compounds have a plurality of asymmetric carbon atoms and corresponding optical isomers can exist, but these optical isomers and their mixtures are to be included in the invention.
- The compounds represented by general formula (1) and (2) in the invention can be prepared according to following preparative processes, making the compounds represented by said general formula (3a) synthesizable from the compounds represented by said general formula (4) and (5) as key intermediates.
- This process is for preparing 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3a) by adding 4,5,6,7-tetrahydroisobenzofuran represented by said general formula (5) to (S)-5-lower alkyl-2(5H)-furanone represented by said general formula (4).
- This reaction can be conducted in the presence or absence of Lewis acid such as zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex or lithium perchlorate, rhodium complex such as Wilkinson's complex, sodium dodecylsulfate or cetyltrimethyl ammonium bromide. The reaction is conducted in the presence or absence of, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, aprotic polar solvent such as acetonitrile, propionitrile, nitromethane, nitroethane, N,N-dimethylformamide or dimethyl sulfoxide, or mixed solvent of one of these with water, and usually proceeds smoothly at -20°C to 200°C. Also, as the case may be, stabilizers like radical eliminator such as 2,6-di-t-butyl-4-methylphenol (BHT), etc. may be added.
- This process is for catalytically reducing the double bond in 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3a), obtainable in the first process aforementioned, to prepare 4,9-epoxyoctahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3b).
- This reaction is conducted usually in solvent, using catalyst such as palladium-carbon, Raney nickel, palladium hydroxide, rhodium-alumina or platinum oxide. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene, or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,3-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of one of these with water is used preferably. The reaction proceeds smoothly at 0°C to 100°C under 101.3KPa to several hundreds KPa.
- This process is for cutting the ether bond of 4,9-epoxydecahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (3b), obtainable in the second process aforementioned, to prepare octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1a).
- This reaction can be conducted usually in the presence of suitable reactant, for example, alkali metal alkoxide such as sodium methoxide or sodium ethoxide, alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide, tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methylmorpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo[4.3.0]nona-5-ene or 1,8-diazabicyclo[5.4.0]ude-7-cene, or Lewis acid such as zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex or lithium perchlorate. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, or ethereal solvent such as diethyl ether, tetrahydofuran or 1,4-dioxane is used preferably. The reaction proceeds smoothly at -110°C to 100°C.
- This process is for isomerizing the double bond of octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1a), obtainable in the third process aforementioned, using a suitable base, to prepare octahydronaphtho-[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1b).
- This reaction can be conducted in the presence of, for example, alkali metal alkoxide such as sodium methoxide or sodium ethoxide, alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide, or tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methyl-morpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo-[4.3.0]nona-5-ene or 1,8-diazabicyclo[5.4.0]unde-7-cene. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably. The reaction proceeds smoothly at -110°C to 100°C .
- This process is for catalytically reducing the double bond in octahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1b), obtainable in the fourth process aforementioned, to prepare decahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1c).
- This reaction is conducted usually in solvent, using catalyst such as palladium-carbon, Raney nickel, palladium hydroxide, rhodium-alumina or platinum oxide. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of one of these with water is used preferably. The reaction proceeds smoothly at 0°C to 100°C under 98.1KPa to several hundreds KPa. Besides, when using platinum oxide for catalyst, only single isomer can be obtained selectively.
- This process is for reducing the lactonecarbonyl bond in decahydronaphtho[2,3-c]furan-1(3H)-one derivatives represented by said general formula (1-1c), obtainable in the fifth process aforementioned, and further for protecting 1-hydroxyl group of 1,4-dihydroxy-dodecahydronaphtho[2,3-c]furan derivatives produced by selective alkylation, to prepare 1-alkoxy-4-hydroxy-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2a).
- The reduction of this reaction is conducted by using dialkylaluminum hydride such as diisobutylaluminum hydride. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, or ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane is used. The reaction proceeds smoothly at -100°C to 100°C. The etherification of 1-position hydroxyl group to be conducted successively is performed in alcohol solvent in the presence of a suitable Lewis acid. As the "suitable Lewis acid", for example, zinc chloride, zinc bromide, zinc iodide, boron trifluoride, aluminum chloride, tin tetrachloride, boron trifluoride-diethyl ether complex, lithium perchlorate or the like is mentioned, and, as the alcohol solvent, for example, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably. The reaction usually proceeds smoothly at -100°C to 100°C.
- Moreover, the introduction of aralkyl group or acyl group to 1-position hydroxyl group to be conducted successively is performed according to publicly known methods (Green, T.W.; Wuts, P.G.M. "Protective Groups in Organic Synthesis", 2nd Ed., Wiley Interscience Publication, John-Weiley & Sons, New York, 1991, pp 46-66 and pp 87-118).
- This process is for oxidizing the 4-position hydroxyl group in 4-hydroxydodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2a), obtainable in the sixth process aforementioned, to prepare 4-oxododecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2b).
- As the oxidizing agent to be used in this process, chromic acid, chromic trioxide-pyridine mixed system, dimethyl sulfoxide-oxalyl chloride-triethylamine mixed system, ruthenium complex, Dess-Martin reagent or the like can be used. The oxidation is usually preferable to be conducted in solvent and, for example, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride is used. The reaction proceeds smoothly at -100°C to 100°C.
- This reaction is for conducing Wittig reaction by reacting ylide prepared from methyltriphenylphosphonium salt and base, with 4-position carbonyl group in 4-oxododecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2b), obtainable in the seventh process aforementioned, to prepare 4-methylenedodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2c).
- As the phosphonium salt to be used in this process, for example, methyltriphenylphosphonium chloride, methyltriphenylphosphonium bromide or methyltriphenylphosphonium iodide is mentioned, and the reaction can be conducted in the presence of, for example, alkali metal alkoxide such as sodium methoxide or sodium ethoxide, alkali metal organic base such as n-butyl lithium, lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide or potassium bis(trimethylsilyl)amide, or tertiary organic base such as triethylamine, diisopropylethylamine, pyridine, N-methylmorpholine, imidazole, pyrrolidine, piperidine, 1,5-diazabicyclo[4.3.0]non-5-ene or 1,8-diazabicyclo[5.4.0]undec-7-ene as a base to be used. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol is used preferably. The reaction proceeds smoothly at -110°C to 100°C.
- This reaction is for conducting hydroboraton and oxidation reaction to 4-position methylene group in 4-methylene-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (1-2c), obtainable in the eighth process aforementioned, to prepare 4-hydroxymethyl-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (2a).
- As a hydroborating agent to be used in this reaction, for example, borane-tetrahydrofuran complex, borane-dimethyl sulfide complex, 9-borabicyclo[3,3,1]nonane or the like is mentioned and, as a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, or mixed solvent thereof is used. The reaction proceeds smoothly at -110°C to 200°C. In the oxidation reaction to be conducted next, aqueous hydrogen peroxide, m-chloroperbenzoic acid, peracetic acid or the like is used. As a solvent, any can be used, if it doesn't take part in the reaction, but, for example, hydrocarbonic solvent such as pentane, hexane, cyclohexane, benzene, toluene or xylene, halogenated hydrocarbonic solvent such as dichloromethane, 1,2-dichloroethane, chloroform or carbon tetrachloride, ethereal solvent such as diethyl ether, tetrahydrofuran or 1,4-dioxane, alcoholic solvent such as methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, 2-methyl-1-propanol or 2-methyl-2-propanol, or mixed solvent of one of these with water is used preferably. The reaction proceeds smoothly at -110°C to 100°C.
- The 4-hydroxy-dodecahydronaphtho[2,3-c]furan derivatives represented by said general formula (2a), synthesized through the synthetic processes as described above are derived to 4-phenylsulfonylmethyl-decahydronaphtho[2,3-c]furan derivatives by sulfonation of 4-position hydroxymethyl group, substitution of 4-position sulfonyloxymethyl group with phenylthio group, and oxidation of 4-position phenylthiomethyl group to phenylsulfonylmethyl group, according to the synthetic method of Kozikowski et al (Kozikowski, A.P. et al, J. Am. Chem. Soc., 1995, 117, 9369) (see Referential example 1).
- Furthermore, the inventors confirmed that, by using 4-phenylsulfonylmethyl-decahydronaphtho[2,3-c]furan derivatives obtained as optically active substances and converting these according to the method described in literature (Kozikowski, A.P. et al, J. Am. Chem. Soc., 1995, 117, 9369), natural type himbacine could be synthesized (see Referential examples 2 through 4).
- In following, the invention will be illustrated in detail bases on examples and Referential examples, but it goes without saying that the invention is not confined to these.
- Best embodiment to put the invention into practice
-
- To 224.0mg(2.28mmol) of (S)-5-methyl-2(5H)-furanone were added 557.9mg(1.5 equivalents) of 4,5,6,7-tetrahydroisobenzofuran in 2ml of dehydrated ether solution and 1.06g of lithium perchlorate, and, after flushing with argon, the mixture was stirred for 168 hours at room temperature. The reaction mixture was poured into 20ml of water, which was extracted with methylene chloride(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off under reduced pressure. The residue was purified by means of silica gel column chromatography(methylene chloride, then methylene chloride:ethyl acetete=10:1) to obtain 292.2mg of (3S, 3aS, 4S, 9R, 9aR)-4,9-epoxy-3-methyl-3a,4,5,6,7,8,9,9a-octahydronaphtho[2,3-c]furan-1(3H)-one (yield 58%) mp. 141-144°C Colorless powdery crystals
1H NMR(400MHz,CDCl3): 1.45(3H,d,J=6.4) 1.48-1.55(2H,m) 1.63-1.71(2H,m) 1.84-1.96(2H,m 2.18-2.30(2H,m) 2.28(1H,dd,J=7.6,3.2) 2.87(1H,d,J=7.8) 4.48(1H,qd,J=6.4,3.4) 4.72(1H,brs) 5.03(1H,brs)
IR(KBr): 1750 cm-1
HRCIMS: Calcd. for C13H17O3: 21.1178 Found: 221.1176 -
- To 79.4mg(0.36mmol) of (3S, 3aS, 4S, 8R, 9aR)-4,9-epoxy-3-methyl-3a,4,5,6,7,8,9,9a-octahydronaphtho[2,3-c]furan-1(3H)-one in 5ml of ethanol solution were added 8.00mg (10% by weight) of 10% palladium-carbon, and catalytic reduction was conducted at ambient temperature under 98.1Kpa. After stirring for 12 hours, the reaction mixture was filtered through celite and the residue was washed using 20ml of ethyl acetate. Combined organic layers were distilled off under reduced pressure to obtain 76.7mg of (3S,3aS,4R,4aS,8aR,9S,9aR)-4,9-epoxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one (yield 96%)
[α]D 20+38° (c 0.51, CHCl3)
mp. 158-159°C (hexane-ethyl acetate) Colorless needle-like crystals
1H NMR(400MHz, CCCl3): δ 1.02-1.18(2H,m) 1.32-1.56(4H,m) 1.40(3H,d,J=6.4) 1.69-1.75(2H,m 2.00-2.15 1.40(3H,d,J=6.4) 1.69-1.75(2H,m 2.00-2.15(2H,m) 2.50(1H,dd,J= 8.3,3.4) 3.12(1H,d,J=7.8) 4.39)1H,qd,J=6.4,3.4) 4.40(1H,dJ= 3.9) 4.75(1H,d,J=4.9)
13C NMR(125MHz, CDCl3): δ 19.5, 19.5, 19.6, 19.9, 22.5, 38.9, 39.7, 45.9, 46.3, 81.2, 83.7, 85.6, 178.0
IR(KBr): 1750 cm-1
HRCIMS: Calcd. for C13H19O3: 223.1334 Found: 223.1338
Elemental analysis: Calcd. for C13H18O3; C: 70.24 H: 8.16
Found; C: 69.97 H: 8.40 -
- To 110.0mg(0.50mmol of (3S,3aS,4R,4aS,8aR,9S,9aR)-4,9-epoxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one in 20ml of dehydrated tetrahydrofuran solution were added dropwise 2.50ml(5 equivalents) of lithium bis(trimethylsilyl)amidetetrahydrofuran solution (1M) at -78°C (internal temperature) under an atmosphere of argon, and the mixture was stirred for about 4 hours while raising temperature naturally. At -40°C, 2ml of saturated aqueous solution of ammonium chloride were added, which was stirred at room temperature, and solvent was distilled off under reduced pressure. To the residue was added 10ml of water, which was extracted with ether (5mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=2:1) to obtain 100.9mg of (3S,3aS,4R,4aS,8aR)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,8a-octahydronaphtho[2,3-c]furan-1(3H)-one (yield 92%). mp. 191-193°C (hexane-ethyl acetate) Colorless powdery crystals
1H NMR(400MHz, CDCl3): δ 0.94-1.29(4H,m) 1.41(1H,d,J=5.4) 1.52)3H,d,J=6.4) 1.56-1.77)(3H,m) 1.94-2.04(2H,m) 2.58-2.64(1H,m)
2.74-2.81(1H,m) 4.01-4.04(1H,m) 4.61(1H,dq,J=9.1,5.9)
6.69(1H,t,J=2.5)
IR(KBr): 1730 cm-1
HRCIMS: Calcd. for C13H18O3; 223.1334 Found; 223.1303
Elemental analysis: Calcd. for C13H18O3; C: 70.24 H: 8.16
Found; C: 70.02 H: 8.13 - Since this compound is unstable at room temperature, next reaction was conducted immediately. To 61.8mg(0.28mmol) of (3S,3aS,4R,4aS,8aR)-4-hydroxy-3-methyl-3a,4,-4a,5,6,7,8,8a-octahydronaphtho[2,3-c]furan-1(3H)-one in 2ml of dehydrated toluene solution were added 207.9µl (5 equivalents) of 1.8-diazabicyclo[5.4.0]undec-7-ene, and the mixture was stirred for 5 hours at about 100°C. After cooling, solvent was distilled off under reduced pressure and 10ml of cold dilute hydrochloric acid were added, which was extracted with methylene chloride(5mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=1:1) to obtain 51.2mg of (3S,3aS,4R,4aS,9aS)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,9a-octahydronaphtho[2,3-c]furan-1(3H)-one (yield 83%).
[α]D 20+148°C (c 0.29, CHCl3)
mp. 166-167 (hexane-ethyl acetate) Colorless platy crystals
1H NMR(500MHz, CDCl3) : δ 1.00(1H,qd,J=12.7,3.5) 1.17-1.32(1H,m)
1.36-1.48(1H,m) 1.52(3H,d,J=6.2) 1.69(1H,d,J=4.2 1.77-1.90(2H,m) 1.95-2.08(2H,m 2.17-2.25(1H,m)
2.33(1H,dt,J=14.2,1.9) 2.56(1H,ddd,J=8.4,8.4,4.7)
3.29(1H,dq,J=8.6,3.0) 3.82(1H,dq,J=4.4,4.4)
4.60(1H,dq,J=8.6,6.2) 5.31(1H,d,J=2.4)
13C NMR(125MHz, CDC13) : δ 21.9, 25.6, 26.9, 31.8, 34.6, 41.0, 43.9, 46.8, 72.4, 77.5, 112.8, 141.1, 176.0
IR(KBr): 1730 cm-1
Elemental analysis: Calcd. for C13H18O3; C: 70.24 H: 8.16
Found; C: 70.29 H: 8.31 -
- To 375.1mg(1.69mmol) of (3S,3aS,4R,4aS, 9aS)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,9a-octahydronaphtho[2,3-c]furan-1(3H)-one in 5ml of ethanol solution were added 40.0mg(10% by weight) of platinum oxide, and catalytic reduction was conducted at ambient temperature under 98.1Kpa. After stirring for 16 hours, the reaction mixture was filtered through celite and the residue was washed using 20ml of ethyl acetate. Combined organic layers were distilled off under reduced pressure and the residue was purified by means of silica gel column chromtography(methylene chloride:ethyl acetate=4:1) to obtain 363.7mg of (3S,3aS,4R,4aS,8aR,9aS)-4-hydroxy-3-methyldecahydronaphtho[2,3-c]furan-1(3H)-one (yield 96%).
[α]D 20-28° (c 0.23, CHCl3)
mp. 195-196°C (hexane-ethyl acetate) Colorless flaky crystals
1H NMR(500MHZ, CDCl3): 0.81-0.92(1H,m) 0.98-1.30(6H,m)
1.54(3H,d,J=6.0) 1.69-1.77(2H,m) 1.74(1H,d,J=4.0) 1.80-1.87(2H,m) 2.04-2.10(1H,m) 2.51(1H,ddd,J=6.7,10.1,6.7)
2.67(1H,dt,J=12.3,6.6) 3.65(1H,ddd,J=10.2,6.1,4.0)
4.73(1H,dq,J=11.9,6.0)
13C NMR(125MHZ, CDCl3): δ 22.1, 25.7, 25.7, 28.9, 31.7, 33.0, 38.6, 41.9, 44.3, 48.2, 73.4, 77.4, 177.8
IR(KBr): 3460, 1740 cm-1
Elemental analysis: Calcd. for C13H20O3; C: 69.61 H: 8.99
Found; C: 69.72 H: 8.93 -
- To 1.88g(8.38mmol) of (3S,3aS,4R,4aS,8aR,9aS)-4-hydroxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one in 200ml of dehydrated ether solution were added dropwise 26.7ml(3 equivalents) of diisobutylalumium hydride-hexane solution(0.94M) at -78°C under an atmosphere of argon. After stirring for about 1 hour at the same temperature, methanol-water mixed solution (10ml+10ml) was added dropwise slowly and the mixture was stirred for 1 hour at room temperature. Solvent was distilled off and 100ml of ethyl acetate were added to the residue, which was filtered through celite, and the residue was washed with ethyl acetate(50ml). Solvent was distilled off and 100ml of saturated brine were added, which was extracted with methylene chloride(30mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off to obtain crude lactol form. This was dissolved into a mixed solution of 50ml of dehydrated methanol with 50ml of dehydrated methylene chloride, 1.55ml(1.5 equivalents) of boron trifluoride-diethyl ether complex were added dropwise at -60°C under an atmosphere of argon, and the mixture was stirred for about 12 hours while raising temperature naturally. To the reaction mixture were added 1.75ml(1.5 equivalents) of triethylamine and, after stirring at room temperature, solvent was distilled of. To the residue was added 100ml of cold dilute aqueous solution of sodium hydrogencarbonate, which was extracted with methylene chloride(30mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=2:1) to obtain 1.50g of (1S,3S,3aS,4R,4aS,8aR,9aS)-4-hydroxy-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan (yield after two processes 74%)
[α]D 20+90° (c 0.21, CHCl3)
mp. 123-124°C (hexane) Colorless needle-like crystals
1H NMR(500MHz, CDCl3) : δ 0.81-1.04(4h,M) 1.13-1.30(3H,m)
1.39(3H,d,J=6.0) 1.45-1.53(2H,m) 1.60-21.74(2H,m) 1.77-1.84(1H,m) 2.04-2.11(1H,m) 2.20(1H,dt,J=12.3,6.0)
2.47(1H,dt,J=9.1,6.0) 3.32(3H,s) 3.64(1H,ddd,J=9.6, 5.7,3.5)
4.30(1H,dq,J=9.1,6.0) 4.53(1H,s)
13C NMR(125MHZ, CDCl3) : δ 25.0, 26.0, 26.0, 29.1, 32.7, 33.4, 38.6, 44.1, 46.0, 48.6, 54.0, 74.6, 76.4, 108.5
IR(KBr): 3407, 2976, 1447, 1437, 1364cm-1
Elemental analysis: Calcd. for C14H24O3; C: 69.96 H: 10.07
Found; C: 69.72 H: 9.82 -
- To 1.23g(5.12mmol) of (1S,3S,3aS,4R,4aS,8aR,9aS)-4-hydroxy-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan and 3.26g of sodium hydrogencarbonate in 100ml of methylene chloride suspension were added 3.26g(1.5 equivalents) of Dess-Martin reagent under stirring and cooling with ice, and the mixture was stirred for 1 hour at room temperature. After 6.35g of sodium thiosulfate 5-hydrate and 50ml of saturated aqueous solution of sodium hydrogencarbonate were added to the reaction mixture and stirred, two layers were separated and extraction with methylene chloride(5mlx3) was performed from aqueous layer. The organic layers were dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=4:1) to obtain 1.18g of (1S,3S,3aR,4aS,8aR,9aS)-1-methoxy-3-methyl-4-oxododecahydronaphtho[2,3-c]furan (yield 97%).
- Also, the synthesis was possible separately through following process. Namely, 0.77g(1.50 equivalents) of N-methylmorpholine and 2.50g of molecular sieve 4A(MS4A) were added to 1.05g(4.37mmol) of (1S,3S,3aS,4R,4aS,8aR,9aS)-4-hydroxy-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan in 10ml of methylene chloride solution, then 76.8mg(0.05 equivalents) of tetrapropylammonium perruthenate(TPAP) were added, and the mixture was stirred for 1.5 hours at room temperature. The reaction mixture was filtered through celite and the residue was washed with ether(100ml). The filtrate was washed with 10% aqueous solution of Na2S2O3 and then with brine (each 20m1x1). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off to obtain 0.99g of (1S,3S,3aR,4aS,8aR,9aS)-1-methoxy-3-methyl-4-oxo-dodecahydronaphtho[2,3-c]furan (yield 95%)
[α]D 20+165° (c 0.16, CHCl3)
mp. 86-87°C (hexane) Colorless platy crystals
1H NMR(500MHz, CDCl3) : δ 1.10-1.50(6H,m) 1.33(3H,d,J=6.1)
1.68-1.86(4H,m) 1.96-2.03(2H,m) 2.59(1H,dt,J=12.7,6.3)
2.80(1H,dd,J=9.1,6.9) 3.32(3H,s) 4.33(1H,dq,J=9.2,6.1)
4.71(1H,s)
13C NMR(125MHz, CDCl3) : δ 22.8, 25.1, 25.5, 25.6, 32.5, 34.3, 41.3, 49.5, 51.4, 54.1, 58.1, 78.4, 109.1, 210.8
IR(KBr): 2926, 1696, 1450 cm-1
Elemental analysis: Calcd. for C14H22O3; C: 70.56 H: 9.30
Found; C: 70.26 H: 9.29 -
- To 9.96g(5 equivalents) of methyltriphenylphosphonium iodide in 400ml of dehydrated ether suspension were added dropwise 4.1ml(5 equivalents) of sodium bis(trimethylsilyl)amide-toluene solution(0.60M) under cooling with ice and under an atmosphere of argon. After stirring for 1 hour at room temperature, 1.17g of (1S,3S,3aR,4aS,8aR,9aS)-1-methoxy-3-methyl-4-oxo-dodecahydronaphtho[2,3-c]furan(4.93mmol) in 30ml of dehydrated ether solution were added dropwise again under cooling with ice. After stirring for 2 hours at room temperature, 50ml of cold saturated aqueous solution of ammonium chloride were added to the reaction mixture and solvent was distilled off. To the residue were poured 100ml of saturated brine, which was extracted with ether(50mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=10:1) to obtain 1.01g of (1S,3S,3aS,4aS,8aR,9aS)-1-methoxy-3-methyl-4-methylene-dodecahydronaphtho[2,3-c]furan (yield 86%).
[α]D 20+56° (c 0.53, CHCl3)
Pale yellow oily product
1H NMR(500MHZ, CDCl3) : 6 0.99-1.33(6H,m) 1.26(3H,d,J=5.8)
1.59-1.73(4H,m) 1.80-1.91(2H,m) 2.25(1H,dt,J=12.2,6.2)
2.73(1H,dd,J=9.4,6.5) 3.33(3H,s) 4.20(1H,dq,J=9.8,6.0)
4.58(1H,s) 4.71(1H,s) 4.82(1H,s)
13C NMR(125MHZ, CDCl3) : δ 21.4, 26.1, 26.4, 28.9, 33.3, 34.5, 41.6, 42.8, 47.9, 53.4, 54.1, 78.2, 109.2, 109.3, 148.8
IR(neat): 2924, 1640, 1451, 1375 cm-1
HRCIMS: Calcd. for C15H25O2: 237.1855 Found: 237.1832 -
- To 99.8mg(0.42mmol) of (1S,3S,3aS,4aS,8aR,9aS)-1-methoxy-3-methyl-4-methylene-dodecahydronaphtho[2,3-c]furan in 10ml of dehydrated tetrahydrofuran solution were added dropwise 633.4µ 1(1.5 equivalents) of borane-tetrahydrofuran complex(1M) under cooling with ice and under an atmosphere of argon, and the mixture was stirred for 4.5 hours while raising temperature naturally. The reaction mixture was cooled with ice and 1ml of water was added to stop the reaction. Then, 0.50ml of 30% aqueous hydrogen peroxide and 0.50 ml of 10% aqueous solution of sodium hydroxide were added, which was stirred for 30 minutes. Solvent was distilled off and 20ml of water were poured to the residue, which was extracted with methylene chloride(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off under reduced pressure. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=4:1, then 1:1) to obtain 86.7mg of (1S,3S,3aR,4R,4aS,8aR,9aS)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan (yield 81%) and 11.7mg of (1S,3S,3aR,4S,4aS,8aR,9aS)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan (yield 11%).
(1S,3S,3aR,4R,4aS,8aR,9aS)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan
[α]D 20+97° (c 0.43, CHCl3)
mp. 97-98°C (hexane) Colorless lattice-like crystals
1H NMR(500MHz, CDCl3) : δ 0.84-1.13(6H,m) 1.18-1.29(2H,m)
1.39(3H,d,J=6.0) 1.49-1.81(5H,m) 1.83-1.89(1H,m)
2.17(1H,dt,J=12.4,6.0) 2.40(1H,dt,J=9.1,5.0) 3.33(3H,S)
3.58-3.65(1H,m) 3.74-3.79(1H,m) 4.23(1H,dq,J=9.3,6.0)
4.48(1H,s)
13C NMR(125MHz, CDCl3): δ 24.2, 26.1, 26.5, 30.2, 33.3,34.1, 38.7, 40.7, 43.9, 45.2, 46.8, 53.9, 62.9, 75.5, 108.1
IR(KBr) : 3453, 2926, 1449, 1395 cm-1
Elemental analysis: Calcd. for C15H26O3; C: 70.83 H: 10.30
Found; C: 70.90 H: 10.49
(1S,3S,3aR,4S,4aS,8aR,9aS)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan
[α]D 20+11° (c 0.46, CHCl3)
Colorless oily product
1H NMR(500MHz, CDCl3) : δ 0.82-0.94(2H,m) 1.14-1.33(6H,m)
1.30(3H,d,J=6.0) 1.41-1.81(6H,m) 2.22(1H,dt,J=13.1,6.3)
2.31(1H,dd,J=9.8,6.3) 3.33(3H,s) 3.56(1H,dd,J=10.6,8.6)
3.84(1H,dd,J=10.6,4.3) 4.15(1H,dq,J=9.9,6.0) 4.53(1H,s)
13C NMR(125MHz, CDCl3): 6 21.8, 26.4, 27.2, 30.5, 33.2, 34.9, 35.0, 39.9, 40.0, 42.6, 44.8, 54.1, 63.1, 77.1, 109.3
IR(KBr): 3422, 2922, 1451, 1375 cm-1
HRCIMS: Calcd. for C15H27O3; 255.1960 Found; 255.1942 -
- To 460.5mg(1.81mmol) of (1S,3S,3aR,4R,4aS,8aR,9aS)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan in 20ml of ethylene chloride solution were added 20.3mg(0.1 equivalent) of 4-(dimethylamino)pyridine and 1.26ml(5 equivalents) of triethylamine, and, after 420.4µl(3 equivalents) of methanesulfonyl chloride were added dropwise under cooling with ice and under an atmosphere of argon, the mixture was stirred for about 3 hours while raising temperature naturally. To the reaction mixture were added 20ml of water to wash, and extraction with methylene chloride(3m1x3) was performed from the aqueous layer. Combined organic layers were dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=2:1) to obtain 645.7mg of O-mesyl form. To 304.7mg(1.5 equivalents) of potassium t-butoxide in 10ml of dehydrated dimethyl sulfoxide solution placed in a 25ml flask were added dropwise 278.8µl(1.5 equivalents) of thiophenol at room temperature under stirring, and the mixture was stirred for 10 minutes. This was added to previous 645.7mg of O-mesyl form in 10ml of dehydrated dimethyl sulfoxide solution, and the mixture was stirred for 3 hours at room temperature. The reaction mixture was poured into 20ml of cold dilute aqueous solution of sodium hydrogencarbonate, which was extracted with ether(10mlx3). After washing the organic layer with saturated brine(10m1x1), it was dried over anhydrous magnesium sulfate, filtered and then solvent was distilled off to obtain phenyl thioether. This was dissolved into 50ml of methylene chloride and 976.3mg(2.5 equivalents) of m-chloroperbenzoic acid(80%) and 760.4mg(5 equivalents) of sodium hydrogencarbonate were added under stirring and cooling with ice. After stirring for 2 hours at room temperature, the reaction mixture was filtered through celite and the residue was washed with methylene chloride(20ml). Solvent was distilled off under reduced pressure and the residue was diluted with 50 ml of ether, which was washed with saturated aqueous solution of sodium hydrogencarbonate(10mlx3) and with saturated brine(10mlx1). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=2:1, then 2:1) to obtain 563.9mg of (1S,3S,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan (yield after 3 processes 82%).
[α]D 20+104° (c 0.35, CHCl3)
(Figure in literature: [α]D 20+100° (c 0.35, CHCl3))
mp. 136-137°C (hexane-ethyl acetate) Colorless powdery crystals
1H NMR(500MHz, CDCl3): δ 0.63(1H,qd,J=12.2,3.0) 0.85-1.03(4H,m) 1.09-1.24(2H,m) 1.45(3H,d,J=6.1) 1.48-1.77(5H,m)
2.06-2.13(1H,m) 2.19(1H,dt,J=12.4,6.0) 2.77(1H,dt,J=8.8,5.5) 2.99(1H,dd,J=14.7,9.5) 3.27(1H,dd,J=14.7,1.7) 3.30(3H,s) 4.09 (1H,dq,J=8.9,6.1) 4.46(1H,S) 7.55-7.61(2H,m) 7.64-7.69(1H,m) 7.89-7.93(2H,m)
13C NMR(125MHz, CDCl3) : δ 25.7, 25.8, 26.5, 29.9, 33.0, 34.1, 36.7, 40.8, 41.0, 45.0, 46.2, 53.9, 55.7, 75.3, 108.3, 127.9, 127.9, 129.3, 129.3, 133.7, 19.9
IR(KBr): 2917, 1447, 1377, 1319m 1144 cm-1
Elemental analysis: Calcd. for C21H30O4S; C: 66.63 H: 7.99
Found; C: 66.33 H: 8.15 -
- To 2.50g(12.5mmol) of (S)-N-tert-butoxycarbonyl-2-methylpiperidine in 25ml of dehydrated diethyl ether solution were added 1.89ml(1 equivalent) of N,N,N',N'-tetramethylethylenediamine at -60°C under an atmosphere of argon, and then 13.3ml(1.1 equivalent) of sec-butyllithium were added dropwise. After the temperature of reaction mixture was raised to -20°C, it was cooled again to -70°C and 1.46ml(1.5 equivalents) of N,N-dimethylformamide were added dropwise. After stirring for about 2 hours, 20ml of saturated solution of ammonium chloride were added to the reaction mixture to stop the reaction. The aqueous layer was separated, which was extracted with ether(10mlx3). Combined organic layers were dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=8:1) to obtain 1.58g of (2R,6S)-tert-butyl 2-formyl-6-methyl-1-piperidinecarboxylate (yield 55%).
[α]D 26+120° (c 1.03, CHCl3)
(Figure in literature
1H NMR(40014Hz, CDCl3): δ 1.12(3H,d,J=6.9) 1.46(9H,s)
1.36-1.77(6H,m) 3.63(1H,dt,J=11.3,3.9) 4.27(1H,brs)
9.30(1H,d,J=3.4) -
- To 201.0mg(0.53mmol) of (1S,3S,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan in 10ml of dehydrated dimethoxyethane solution were added dropwise 689.6µ 1(2 equivalents) of n-butyllithium-hexane solution(1.54M) at -78°C (external temperature) under an atmosphere of argon. After stirring for 10 minutes, 241.4mg(2 equivalents) of (2R,6S)-tert-butyl 2-formyl-6-methyl-1-piperidinecarboxylate in 2ml of dehydrated dimethoxyethane solution were added dropwise, which was stirred for 1 hour while raising temperature naturally. To the reaction mixture were added 10ml of water to stop the reaction, which was diluted with 20ml of saturated brine and extracted with ether(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=9:1, then 1:1) to obtain 145.0mg(yield 45%) of coupling resultant as a mixture of diastereomer together with 111.0mg(yield 55%) of starting material (1S,3S.,3aS,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan. The 1H NMR(400MHz, CDCl3) spectrum of this compound showed signals of complicated mixture, but, since four signals of 6 1.46(9H,s), δ 3.34(3H,s),δ 7.90-8.04(3H,m) and 6 7.52-7.68(2H,m) could be identified, the inventors assumed this as a coupling resultant.
- To 333.9mg of said coupling resultant in 14ml of methanol solution were added 5.96g of sodium amalgam(5%) and 1.08g of disodium hydrogenphosphate at room temperature under stirring, and the mixture was stirred for 2.5 hours. To the reaction mixture were added 10ml of water to stop the reaction and solvent was distilled off under reduced pressure. The residue was diluted with 20ml of saturated brine, which was extracted with ether(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. The residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=5:1) to obtain 162.4mg of (2R,6S)-tert-butyl 2-[(E)-2-[(1S,3S,3aR,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate(yield after 2 processes 66%). [α]D 25+102° (c 0.43, CHCl3)
(Figure in literature
1H NMR(400MHZ, CDCl3):δ 0.63-0.74(1H,m) 0.87-1.01(4H,m)
1.16-1.34(3H,m) 1.23(3H,d,J=6.9) 1.29(3H,d,J=5.9) 1.44(9H,s)
1.46-1.79(8H,m) 1.87-2.08(3H,m) 2.14-2.22(2H,m) 3.31(3H,s)
3.95-4.02(1H,m) 4.18(1H,dq,J=8.3,6.4) 4.41(1H,brs) 4.48(1H,s)
5.21(1H,dd,J=15.2,10.3) 5.47(1H,dd,J=15.2,6.4)
HREIMS: Calcd. for C27H45NO4; 447.3349 Found; 447.3342 -
- To 154.7mg(0.35mmol) of (2R,6S)-tert-butyl-2-[(E)-2-[(1S,3S,3aR,4R,4aS,8aR,9aS)-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate in 6ml of acetone solution were added 0.90ml of Jones reagent at room temperature under stirring. After stirring for 30 minutes, 10ml of water were added to the reaction mixture to stop the reaction and solvent was distilled off under reduced pressure. The residue was diluted with 10ml of saturated brine, which was extracted with ether(5mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off to obtain crude (2R,6S)-tert-butyl 2-[(E)-2-[(3S,3aR,4R,raS,8aR,9aS-3-methyl-1-oxo-dodecahydronaphtho[2,3-c]furan-4-yl)vinyl]-6-methyl-1-piperidinecarboxylate. To this were added 2ml of methylene chloride to make a solution, and 1.00ml of trifluoroacetic acid was added, which was stirred for 1.5 hours at room temperature. To the reaction mixture were added 20ml of cold dilute aqueous solution of sodium hydroxide to make alkaline, and solvent was distilled off under reduced pressure. The residue was extracted with ether(5mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off to obtain 133.2mg of crude (3S,3aR,4R,raS,8aR,9aS)-3-methyl-4-[(E)-2-[(2R,6S)-6-methylpiperidin-2-yl]vinyl-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one.
- To 133.2mg of crude (3S,3aR.4R,4aS,8aR,9aS)-3-methyl-4-[(E)-2-[(2R,6S)-6-methylpiperidine-2-yl]vinyl)-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one in 6ml of acetonitrile solution were added 0.30ml of 37% formaldehyde solution and then 47.8mg(2.2 equivalents) of sodium cyanoborohydride at room temperature under stirring, and the mixture was stirred for 30 minutes. Acetic acid was added to the reaction mixture to make neutral and, after stirring further for 1 hour, 20ml of cold dilute aqueous solution of sodium hydroxide were added to make alkaline and solvent was distilled off under reduced pressure. The residue was extracted with ether(10mlx3). The organic layer was dried over anhydrous magnesium sulfate, filtered and solvent was distilled off. the residue was purified by means of silica gel column chromatography(hexane:ethyl acetate=5:1, then 1:1) to obtain 108.8mg of (3S,3aR,4R,4aS,8aR,9aS)-4-[(E)-2-[(2R,6S)-1.6-dimethylpiperidine-2-yl]vinyl)-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(himbacine)(yield after 3 processes 91%).
[α]D 24+55° (c 0.21, CHCl3)
Standard articled [α]D 24+56° (c 0.21, CHCl3) ;
[α]D 20+51.4° (c 1.01, CHCl3)
mp. 127-128°C (hexane) Colorless powdery crystals
Standard article
1H NMR(400MHz, CDCl3) : δ 0.70-0.75(1H,m) 0.93-1.06(3H,m)
1.00(3H,d,J=6.4) 1.12-1.28(3H,m) 1.38-1.47(2H,m)
1.40(3H,d,J=6.4) 1.50-1.61(2H,m) 1.64-1.80(6H,m)
1.87(1H,ddd,J=13.2,5.9,2.4) 2.07-2.14(1H,m) 2.22(3H,s)
2.22-2.27(1H,m) 2.63(1H,dt,J=13.2,6.7) 2.80-2.87(1H,m)
2.99-3.06(1H,m) 4.63(1H,dq,J=11.0,5.9) 5.26(1H,dd,J=15.2,9.8) 5.58)1H,dd,J=15.0,9-1)
13C NMR(100MHz, CDCl3) : δ 14.0, 19.0, 22.2, 26.1, 26.5, 31.5, 32.1, 32.6, 33.3, 33.6, 39.9, 41.2, 41.6, 42.3, 45.8, 49.2, 53.4, 61.4) 76.8, 133.4, 133.6, 178.3
IR(KBr): 2932, 2848, 1793, 1449 cm-1
HREIMS: Calcd. for C22H35NO2; 345.2688 Found; 345.2696 -
- Similarly to Example 1, 1.37g(13.9mmol) of (R)-5-methyl-2(5H)-furanone and 1.70g(1 equivalent) of 4,4,6,7-tetrahydroisobenzofuran in 2ml of dehydrated ether solution were reacted with 1.06g of lithium perchlorate to obtain 2.20g of (3R,3aR,4R,95,9aS)-4,9-epoxy-3-methyl-3a,4,5,6,7,8,9,9a-octahydronaphtho[2,3-c]furan-1(3H)-one(yield 72%).
-
- Similarly to Example 2, 0.22g(10% by weight) of 10% palladium-carbon were added to 2.20g(9.99mmol) of (3R,3aR,4R,9S,9aS)-4,9-epoxy-3-methyl-3a,4,5,6,7,8,9,9a-octahydronaphtho[2,3-c]furan-1(3H)-one in 5ml of ethanol solution and catalytic reduction was conducted at ambient temperature under 98.1Kpa to obtain 1.36g of (3R,3aR,4S,4aR,8aS,9R,9aS)-4,9-epoxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(yield 61%).
[α]D 23-50° (c 0.68, CHCl3)
mp.148-149°C (hexane-ethyl acetate) Colorless flaky crystals -
- Similarly to Example 3, 1.35g(6.07mmol) of (3R,3aR,4S,4aR,8aS,9R,9aS)-4,9-epoxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one were reacted with 27.6mg(5 equivalents) of lithium bis(trimethylsilyl)amide-tetrahydrofuran solution(1.1M) to obtain 1.37g of (3R,3aR,4S,4aR,8aS)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,8a-octahydronaphtho[2,3-c]furan-1(3H)-one and then reacted with 4.54ml(5 equivalents) of 1,8-diazabicyclo[5.4.0]undec-7-ene to obtain 1.05g of (3R,3aR,4S,4aR,9aR)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,9a-octahydronaphtho[2,3-c]furan-1(3H)-one(yield after 2 processes 78%).
[α]D 16-160° (c 0.27, CHCl3)
mp.156-157°C (hexane-ethyl acetate) Colorless lattice-like crystals -
- Similarly to Example 4, 1.04g(4.68mmol) of (3R,3aR,4S,4aR,9aR)-4-hydroxy-3-methyl-3a,4,4a,5,6,7,8,9a-octahydronaphtho[2,3-c]furan-1(3H)-one were catalytically reduced at ambient temperature under 98.1KPa of (3R,3aR,4S,4aR,8aS,9aR)-4-hydroxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(yield 93%).
[α]D 22+69° (c 0.33, CHCl3)
mp. 185-186°C (hexane-ethyl acetate) Colorless platy crystals -
- Similarly to Example 5, 0.98g(4.37mmol) of (3R,3aR,4S,4aR,8aS,9aR)-4-hydroxy-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one were reacted with 13.8ml(3 equivalents) of diisobutylaluminum hydride-hexane solution(0.95M) to convert to crude lactol form and then reacted with 20ml of methanol and 0.81ml(1.5 equivalents) of boron trifluoride-diethyl ether complex to obtain 0.89g of (1R,3R,3aR,4S,4aR,8aS,9aR)-4-hydroxy-1-methoxy-3-methyl-decahydronaphtho[2,3-c]furan(yield after 2 processes 85%).
[α]D 21+95° (c 0.34, CHCl3)
mp. 118-119°C (hexane) Colorless needle-like crystals -
- Similarly to Example 6, 866.0g(3.60mmol) of (1R,3R,3aR,4S,4aR,8aS,9aR)-4-hydroxy-1-methoxy-3-methyl-decahydronaphtho[2,3-c]furan were oxidized with 63.3mg(0.05 equivalents) of tetrapropylammonium perruthenate, 633.2mg(1.5 equivalents) of N-methylmorpholine and 1.80g of MS4A to obtain 786.0mg of (1R,3R,3aS,4aR,8aS,8aS,9aR)-1-methoxy-3-methyl-4-oxo-dodecahydronaphtho[2,3-c]furan(yield 92%).
[α]D 21+165° (c 0.41, CHCl3)
mp. 86-87°C (hexane) Colorless platy crystals -
- Similarly to Example 7, 6665.6mg(5 equivalents) of methyltriphenylphosphonium iodide and 16.5ml(5 equivalents) of sodium bis(trimethylsilyl)amide-toluene solution(1M) were reacted with 786.0mg of (1R,3R,3aS,4aR,8aS,9aR)-1-methoxy-3-methyl-4-Oxo-dodecahydronaphtho[2,3-c]furan to obtain 683.5mg of (1R,3R,3aR,4aR,8aS,9aR)-1-methoxy-3-methyl-4-methylene-dodecahydronaphtho[2,3-c]furan(yield 88%).
[α]D 23+58° (c 0.29, CHCl3)
Pale yellow oily product -
- Similarly to Example 8, after 663.7mg(2.81mmol) of (1R,3R,3aR,4aR,8aS,9aR)-1-methoxy-3-methyl-4-methylene-dodecahydronaphtho[2,3-c]furan were reacted with 4.21ml (1.5 equivalents) of borane-tetrahydrofuran complex(1M), it was oxidized by adding 3.00ml of 30% hydrogen peroxide solution and 3.00ml of 10% aqueous solution of sodium hydroxide to obtain 538.2mg of (1R,3R,3aS,4S,4aR,8aS,9aR)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan(yield 75%) and 55.2mg of (1R,3R,3aS,4R,4aR,8aS,9aR)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan(8%).
(1R,3R,3aS,4S,4aR,8aS,9aR)-4-hydoxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan
[α]D 22+84° (c 0.53, CHCl3)
mp. 93-94°C (hexane) Colorless needle-like crystals
(1R,3R,3aS,4R,4aR,8aS,9aR)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan
[α]D 22+10° (c 0.42, CHCl3)
Yellow oily product - similarly to Referential example 1, 532.4mg(2.09mmol) of (1R,3R,3aS,4S,4aR,8aS,9aR)-4-hydroxymethyl-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan were mesylated with 486.0µ1(3 equivalents) of methanesulfonyl chloride, 1458.6µ1(5 equivalents) of triethylamine and 23.5mg(0.1 equivalent) of 4-(dimethylamino)pyridine to obtain 687.5mg of yellow oily O-mesyl form. Then, this was converted to phenylthio form with 348.1mg(1.5equivalents) of potassium t-butoxide and 318,5µ 1(1.5 equivalents) of thiophenol and further oxidized with 1290.0mg(2.5 equivalents) of m-chloroperbenzoic acid(70%) and 879.2mg(5 equivalents) of sodium hydrogencarbonate to obtain 311.2mg of (1R,3R,3aR,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan(yield after 3 processes 39%).
[α]D 22-104° (c 0.35, CHCl3)
mp. 129-130°C (hexane-ethyl acetate) Colorless powdery crystals -
- Similarly to Referential example 2, 2.10g(10.5mmol) of (R)-N-tert-butoxycarbonyl-2-methylpiperidine were reacted with 1.59ml(1 equivalent) of N,N,N',N'-tetramethylethylenediamine, 111.1ml(1.1 equivalent) of sec-butyllithium(1.04M) and 1.22ml(1.5 equivalents) of N,N-dimethylformamide to obtain 1.67g of (2S,6R)-tert-butyl 2-formyl-6-methyl-1-piperidinecarboxylate(yield 70%).
[α]D 22+128° (c 0.82, CHCl3) -
- Similarly to Referential example 3, 282.9mg(0.75mmol) of (1R,3R,3aR,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan were reacted with 952.1µ 1(2 equivalents) of n-butyllithium-hexane solution(1.57M) and then with 339.8mg(2 equivalents) of (2S,6R)-tert-butyl 2-formyl-6-methyl-1-piperidinecarboxylate to obtain 233.7mg(yield 52%) of coupling resultant as a mixture of diastereomer together with 135.7mg(48%) of starting material (1R,3R,3aR,45,4aR,8aS,9aR)-1-methoxy-3-methyl-4-(phenylsulfonyl)methyl-dodecahydronaphtho[2,3-c]furan. Then, 5.50g of sodium amalgam(5%) and 1.00g of disodium hydrogenphosphate were reacted to obtain 110.2mg of (2S,6R)-tert-butyl 2-[(E)-2-(1R,3R,3aS,4S14aR,8aS,9aR)-1-methoxy-3-methyl-dodecahydronaphthd[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate(yield after 2 processes 64%).
[α]D 23+88° (c 0.35, CHCl3)
mp. 90-92°C Colorless powdery crystals -
- Similarly to Referential example 4, 156.0mg(0.35mmol) of (2S,6R)-tert-butyl 2-[(E)-2-[(1R,3R,3aS,4S,4aR,8aS,9aR)-1-methoxy-3-methyl-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate were reacted with 0.90ml of Jones reagent to obtain 147.1mg of (2S,6R)-tert-butyl 2-[(E)-2-[(3R,3aS,4S,4aR,8aS,9aR)-3-methyl-1-oxo-dodecahydronaphtho[2,3-c]furan-4-yl]vinyl]-6-methyl-1-piperidinecarboxylate, and then 1.00ml of trifluoroacetic acid was reacted to obtain 113.0mg of crude (3R,3a5,45,4aR,8a5,9aR)-3-methyl-4-[(E)-2-[(25,6R)-6-methylpiperidine-2-yl]vinyl]-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one(yield after 2 processes 98%). Then, 0.30ml of 37% formaldehyde solution and 47.1mg (2.2 equivalents) of sodium cyanoboronhydride were reacted to obtain 100.8mg of (3R,3aS,4S,4aR,8aS,9aR)-4-[(E)-2-[(2S,6R)-1.6-dimethylpiperidine-2-yl]vinyl]-3-methyl-decahydronaphtho[2,3-c]furan-1(3H)-one (ent-himbacine)(yield after 3 processes 84%).
[α]D 23+59° (c 0.29, CHCl3)
mp. 128-130°C (hexane) Colorless powdery crystals
Claims (6)
- Hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, R5 and R6 unitedly denote an oxygen atom, or R5 denotes a hydrogen atom and R6 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and, in the case of broken line accompanied, one denotes single bond and the other denotes double bond, or both denote single bonds).
- Hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1-1) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and, in the case of broken lines accompanied, one denotes single bond and the other denotes double bond, or both denote single bonds).
- Hydronaphtho[2,3-c]furan derivatives represented by a following general formula (1-2) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R3 and R4 unitedly denote an oxygen atom or methylene group, or R3 denotes a hydrogen atom and R4 denotes a hydroxyl group, lower alkoxy group, substituted or unsubstituted aralkyloxy group or lower acyloxy group, and R7 denotes a hydrogen atom, lower alkyl group, substituted or unsubstituted aralkyl group or lower acyl group).
- Hydronaphtho[2,3-c]furan derivatives represented by a following general formula (2) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, R7 denotes a hydrogen atom, lower alkyl group, substituted or unsubstituted aralkyl group or lower acyl group, and R8 denotes a hydrogen atom or protective group of hydroxyl group).
- Hydronaphtho[2,3-c]furan derivatives represented by a following general formula (3) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group, and, in the case of broken line accompanied, it denotes single bond or double bond).
- A process for preparing compounds represented by following general formula (3a) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group, and R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group), characterized by reacting compounds represented by a following general formula (4) (wherein R1 denotes a lower alkyl group or substituted or unsubstituted aralkyl group), with compounds represented by a following general formula (5) (wherein R2 denotes a hydrogen atom, lower alkyl group or substituted or unsubstituted aralkyl group).
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35299198 | 1998-12-11 | ||
JP35299198 | 1998-12-11 | ||
JP11348326A JP2000229961A (en) | 1998-12-11 | 1999-12-08 | Hydronaphtho[2,3-c]furan derivative and its production |
JP34832699 | 1999-12-08 | ||
PCT/JP1999/006937 WO2000035898A1 (en) | 1998-12-11 | 1999-12-10 | HYDRONAPHTHO[2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1138679A1 true EP1138679A1 (en) | 2001-10-04 |
EP1138679A4 EP1138679A4 (en) | 2002-01-16 |
EP1138679B1 EP1138679B1 (en) | 2003-03-19 |
Family
ID=26578721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99959746A Expired - Lifetime EP1138679B1 (en) | 1998-12-11 | 1999-12-10 | HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF |
Country Status (9)
Country | Link |
---|---|
US (1) | US6392059B1 (en) |
EP (1) | EP1138679B1 (en) |
JP (1) | JP2000229961A (en) |
AT (1) | ATE234828T1 (en) |
AU (1) | AU1683500A (en) |
CA (1) | CA2354516A1 (en) |
DE (1) | DE69906131T2 (en) |
DK (1) | DK1138679T3 (en) |
WO (1) | WO2000035898A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003033501A1 (en) * | 2001-10-18 | 2003-04-24 | Schering Corporation | Himbacine analogues as thrombin receptor antagonists |
CN108779255A (en) * | 2016-03-15 | 2018-11-09 | Sika技术股份公司 | Polymeric blends containing at least two different comb polymers |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK287026B6 (en) * | 2000-06-15 | 2009-10-07 | Schering Corporation | Nor-seko-himbacine derivates, pharmaceutical composition comprising the same and their use |
US7488742B2 (en) * | 2000-06-15 | 2009-02-10 | Schering Corporation | Thrombin receptor antagonists |
JPWO2003055871A1 (en) * | 2001-12-25 | 2005-05-12 | 財団法人相模中央化学研究所 | Decahydronaphtho [2,3-c] furan derivative |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999026943A1 (en) * | 1997-11-25 | 1999-06-03 | Schering Corporation | Thrombin receptor antagonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716952A (en) | 1992-03-18 | 1998-02-10 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
US6063847A (en) * | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
-
1999
- 1999-12-08 JP JP11348326A patent/JP2000229961A/en active Pending
- 1999-12-10 AT AT99959746T patent/ATE234828T1/en not_active IP Right Cessation
- 1999-12-10 US US09/856,462 patent/US6392059B1/en not_active Expired - Fee Related
- 1999-12-10 DE DE69906131T patent/DE69906131T2/en not_active Expired - Fee Related
- 1999-12-10 AU AU16835/00A patent/AU1683500A/en not_active Abandoned
- 1999-12-10 CA CA002354516A patent/CA2354516A1/en not_active Abandoned
- 1999-12-10 DK DK99959746T patent/DK1138679T3/en active
- 1999-12-10 EP EP99959746A patent/EP1138679B1/en not_active Expired - Lifetime
- 1999-12-10 WO PCT/JP1999/006937 patent/WO2000035898A1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999026943A1 (en) * | 1997-11-25 | 1999-06-03 | Schering Corporation | Thrombin receptor antagonists |
Non-Patent Citations (4)
Title |
---|
CHACKALAMANNIL S ET AL: "A highly efficient total synthesis of (+)-Himbacine" JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 118, no. 40, 9 October 1996 (1996-10-09), pages 9812-9813, XP002095052 ISSN: 0002-7863 * |
DOLLER D ET AL: "Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 9, no. 6, 22 March 1999 (1999-03-22), pages 901-906, XP004160496 ISSN: 0960-894X * |
See also references of WO0035898A1 * |
TAKADOI M ET AL: "A Novel Total Synthesis of (+)-Himbacine, A Potent Antagonist of the Muscarinic Receptor of M2 Subtype" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 40, no. 17, 23 April 1999 (1999-04-23), pages 3399-3402, XP004162293 ISSN: 0040-4039 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003033501A1 (en) * | 2001-10-18 | 2003-04-24 | Schering Corporation | Himbacine analogues as thrombin receptor antagonists |
US7037920B2 (en) | 2001-10-18 | 2006-05-02 | Schering Corporation | Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
KR100960170B1 (en) * | 2001-10-18 | 2010-05-26 | 쉐링 코포레이션 | Himbacine analogues as thrombin receptor antagonists |
CN108779255A (en) * | 2016-03-15 | 2018-11-09 | Sika技术股份公司 | Polymeric blends containing at least two different comb polymers |
CN108779255B (en) * | 2016-03-15 | 2021-06-11 | Sika技术股份公司 | Polymer mixture containing at least two different comb polymers |
Also Published As
Publication number | Publication date |
---|---|
WO2000035898A1 (en) | 2000-06-22 |
AU1683500A (en) | 2000-07-03 |
ATE234828T1 (en) | 2003-04-15 |
CA2354516A1 (en) | 2000-06-22 |
JP2000229961A (en) | 2000-08-22 |
EP1138679B1 (en) | 2003-03-19 |
DK1138679T3 (en) | 2003-04-22 |
EP1138679A4 (en) | 2002-01-16 |
DE69906131T2 (en) | 2004-01-29 |
US6392059B1 (en) | 2002-05-21 |
DE69906131D1 (en) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Danishefsky et al. | Chelation-controlled facially selective cyclocondensation reactions of chiral alkoxy aldehydes: Syntheses of a mouse androgen and of a carbon-linked disaccharide | |
Nicolaou et al. | Bridging of macrodithionolactones to bicyclic systems. Synthesis and modeling of oxapolycyclic frameworks | |
Guindon et al. | Regiocontrolled opening of cyclic ethers using dimethylboron bromide | |
Schwartz et al. | New tandem radical cyclizations directed toward the synthesis of Crinipellin A | |
Aristoff et al. | Total synthesis of a novel antiulcer agent via a modification of the intramolecular Wadsworth-Emmons-Wittig reaction | |
EP2495235B1 (en) | Process for the synthesis of prostaglandins and intermediates thereof | |
Flann et al. | Enantioselective total synthesis of streptazolin. The tandem use of iminium ion vinylsilane cyclizations and intramolecular acylations | |
EP0045118A2 (en) | Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2Z-enes | |
US3822254A (en) | Synthesis of 25-hydroxycholesterol | |
JPS6087278A (en) | 7-oxabicyclo substituted prostaglandin phenylcarboxylic acid derivative | |
AU607337B2 (en) | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof | |
Pal et al. | Benzoxazole alkaloids: occurrence, chemistry, and biology | |
Suryawanshi et al. | Bruceantin support studies. 10. Use of an axial. alpha.-face control element in intramolecular conjugate additions: synthesis of an ABCD tetracyclic bruceantin precursor | |
EP1138679B1 (en) | HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
Suemune et al. | Conversion of limonene to prostanoic acid and 8-isoprostanoic acid | |
Mantell et al. | 3-Hydroxymuscarines from L-rhamnose | |
WO2006070671A1 (en) | 12-position substituted mutilin derivative | |
HU211554A9 (en) | Circulation-active dibenzo/1,5/dioxocin-5-ones | |
Koskinen et al. | Polyhydroxylated indolizidine alkaloids—an efficient synthesis of 1-deoxy-8, 8a-di-epi-castanospermine | |
Takadoi et al. | Synthetic studies on himbacine, a potent antagonist of the muscarinic M2 subtype receptor. Part 2: Synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety | |
Marcos et al. | Synthesis of (+)-limonidilactone and 12-epi-limonidilactone | |
NINOMIYA et al. | Photocyclization of Enamides. XXXIII. Total Syntheses of (±)-Agroclavines,(±)-Fumigaclavine B, and (±)-Lysergene | |
Siewert et al. | Spirodionic acid, a novel metabolite from Streptomyces sp., part 2: total synthesis through a twofold Michael addition as a selective spiroannelation strategy | |
KR840000948B1 (en) | Process for the preparation of 9-deoxy-9a-methylene isosteres of pgi2 | |
US20050124658A1 (en) | Decahydronaphtho[2,3-c]furan derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010606 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 20010606;LT PAYMENT 20010606;LV PAYMENT 20010606;MK PAYMENT 20010606;RO PAYMENT 20010606;SI PAYMENT 20010606 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011129 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 20020610 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20030319 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 Ref country code: CH Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030319 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REF | Corresponds to: |
Ref document number: 69906131 Country of ref document: DE Date of ref document: 20030424 Kind code of ref document: P |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030619 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030620 |
|
LTIE | Lt: invalidation of european patent or patent extension |
Effective date: 20030319 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20030930 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
ET | Fr: translation filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031210 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031210 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20031210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031231 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20031222 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20061206 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20061207 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20061208 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20061217 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20061227 Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20071210 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20080701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080701 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20081020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080701 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20080102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071231 |